A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

More information: Ka Wo Wong et al, Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma ...